Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm A Martin

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Virology|August 5, 2011
Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDSYoshiaki Nishimura, Masashi Shingai, Wendy R Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2020
Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitorYoshiaki Nishimura, J Nicholas Francis, Olivia K Donau, et al.
Journal of Virology|December 12, 2001
Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronousTatsuhiko Igarashi, Charles R Brown, Russell A Byrum, et al.
Nature Medicine|April 18, 2018
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infectionRajeev Gautam, Yoshiaki Nishimura, Natalie Gaughan, et al.
The Journal of Experimental Medicine|September 23, 2020
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremiaYoshiaki Nishimura, Olivia K Donau, Joana Dias, et al.
Journal of Virology|February 12, 2010
Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaquesYoshiaki Nishimura, Masashi Shingai, Ronald Willey, et al.
Journal of Virology|December 28, 2002
Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particlesRonald L Willey, Russ Byrum, Michael Piatak, et al.
Nature|November 1, 2013
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemiaMasashi Shingai, Yoshiaki Nishimura, Florian Klein, et al.
Journal of Virology|November 10, 2006
Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaquesYoshiaki Nishimura, Tatsuhiko Igarashi, Alicia Buckler-White, et al.
Journal of Virology|December 3, 2003
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophagesTatsuhiko Igarashi, Olivia K Donau, Hiromi Imamichi, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Virology|August 5, 2011
Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDSYoshiaki Nishimura, Masashi Shingai, Wendy R Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2020
Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitorYoshiaki Nishimura, J Nicholas Francis, Olivia K Donau, et al.
Journal of Virology|December 12, 2001
Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronousTatsuhiko Igarashi, Charles R Brown, Russell A Byrum, et al.
Nature Medicine|April 18, 2018
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infectionRajeev Gautam, Yoshiaki Nishimura, Natalie Gaughan, et al.
The Journal of Experimental Medicine|September 23, 2020
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremiaYoshiaki Nishimura, Olivia K Donau, Joana Dias, et al.
Journal of Virology|February 12, 2010
Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaquesYoshiaki Nishimura, Masashi Shingai, Ronald Willey, et al.
Journal of Virology|December 28, 2002
Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particlesRonald L Willey, Russ Byrum, Michael Piatak, et al.
Nature|November 1, 2013
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemiaMasashi Shingai, Yoshiaki Nishimura, Florian Klein, et al.
Journal of Virology|November 10, 2006
Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaquesYoshiaki Nishimura, Tatsuhiko Igarashi, Alicia Buckler-White, et al.
Journal of Virology|December 3, 2003
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophagesTatsuhiko Igarashi, Olivia K Donau, Hiromi Imamichi, et al.
Pageof 7